Sulphation and glucuronidation of xamoterol in the dog: Dose dependence and site of sulphation
- 1 January 1988
- journal article
- research article
- Published by Taylor & Francis in Xenobiotica
- Vol. 18 (5) , 511-518
- https://doi.org/10.3109/00498258809041688
Abstract
1. Xamoterol has been administered both intravenously and orally over a 100-fold dose range to male beagle dogs. 2. Over the dose range examined, sulphation was not saturable, with the proportion of the dose excreted as the sulphate conjugate remaining constant. 3. Extensive first-pass sulphation of an oral dose of xamoterol occurred in the intestine with approximately 50% of sulphation occurring during absorption. 4. The intestine is not a major site of sulphation for circulating xamoterol. 5. The liver is not believed to play an important role in the first-pass sulphation of xamoterol.This publication has 7 references indexed in Scilit:
- Pharmacokinetics of xamoterol glucuronidation in the ratin vivoand in liver perfusionXenobiotica, 1987
- The in vitro pharmacology of xamoterol (ICI 118,587)British Journal of Pharmacology, 1985
- DOSE-DEPENDENT SULFOCONJUGATION OF SALICYLAMIDE IN DOGS - EFFECT OF SULFATE DEPLETION OR ADMINISTRATION1985
- High-rate intestinal conjugation of 4-methylumbelliferone during intravenous infusion in the ratBiochemical Pharmacology, 1984
- THE METABOLISM OF ICI 118,587, A PARTIAL AGONIST OF BETA-1-ADRENOCEPTORS, IN MICE, RATS, RABBITS, DOGS, AND HUMANS1984
- Hepatic and extrahepatic glucuronidation of lorazepam in the dogHepatology, 1981
- Drug Metabolism by the Gastrointestinal MucosaClinical Pharmacokinetics, 1981